EVLV Q1 2026: 45% Revenue Surge Anchored by 64% Purchase Deal Mix Shift

2026-05-12 | By EarningsIQ Research

Evolve Technology’s Q1 results highlight a pivotal shift in deal structure, with purchase deals rising to 64% of mix, fueling a sharp top-line acceleration but introducing short-term margin headwinds. The company’s hardware-enabled subscription model continues to drive recurring revenue scale and deepen customer integration across education, healthcare, and enterprise segments. Upwardly revised guidance and an expanding installed base signal management’s conviction in durable growth and long-term operating leverage.

Summary

  • Deal Mix Shift: Higher share of purchase deals drove upfront revenue but tempered margin expansion.
  • Recurring Revenue Scale: Installed base growth and Expedite adoption are building subscription stickiness.
  • Margin Leverage Path: Management signals long-term EBITDA margin potential well above prior targets.

Business Overview

Evolve Technology (EVLV) provides AI-powered weapons detection systems, delivering security screening solutions to schools, hospitals, sports venues, and enterprise workplaces. The company monetizes through a hybrid model: purchase deals (hardware and upfront product revenue plus recurring service fees) and full subscription deals (all-in recurring revenue). Its core offerings, Express (walkthrough screening) and Expedite (autonomous bag screening), are delivered as a service, with multi-year contracts driving annual recurring revenue (ARR).

Performance Analysis

Evolve reported Q1 revenue of $46.3 million, up 45% year over year, propelled by a record mix of purchase deals (64% of total, up from the historical 50-60% range). This shift produced a one-time revenue lift, as purchase transactions recognize more product revenue upfront compared to subscription contracts. However, this also created a gross margin headwind, with adjusted gross margin stepping down to 52% from 61% a year ago, as hardware costs were recognized immediately rather than amortized.

ARR reached $127.3 million, up 20% year over year, reflecting expansion across 1,300 customers and strong multi-year contract momentum. Remaining performance obligation (RPO) grew 18% to $299 million, driven by Gen2 Express upgrades and new deployments. Adjusted EBITDA margin expanded to 8.5%, up from 6.4%, as scale and operational discipline offset higher R&D and G&A investment. Cash usage was in line with expectations, with management reiterating a move to cash flow positivity in H2 2026.

  • Purchase Deal Mix Surge: 64% of Q1 deals were purchase-based, boosting upfront revenue but compressing gross margin.
  • Expedite Adoption: Expedite now in 6% of customer base (up from 1% YoY), with 19% of new customers taking both Express and Expedite.
  • Upgraded Guidance: Full-year revenue outlook raised, reflecting higher purchase mix and pricing strength.

The company’s fulfillment and pricing model transition in mid-2025 continues to impact revenue timing and margin profile, but management expects normalization post-2026 as recurring revenue becomes a larger share of the mix.

Executive Commentary

"We continue to execute on what we said we would do. The progress we're making starts with the trust and partnership of our customers, and it's being delivered through the steady, disciplined work of our team. We continue to strengthen the consistency and reliability of our operations while scaling a hardware-enabled subscription business that is producing increasingly predictable and durable outcomes."

John Kaczorski, President and Chief Executive Officer

"Our intentional shift of purchase subscriptions to direct fulfillment creates an initial gross margin headwind. This outcome is fully aligned with our strategy. Although margin stepped down in the first quarter of a new deployment, the direct model produces superior long-term returns, including higher total gross profit, increased revenue and ARR, and a better cash flow than our prior distribution approach."

Chris Cutzer, Chief Financial Officer

Strategic Positioning

1. Hardware-Enabled Subscription Model Drives Predictability

Evolve’s model blends proprietary hardware, AI-enabled software, and field services into a multi-year contract structure, producing durable ARR and deep customer integration. The shift to direct fulfillment increases upfront revenue and long-term profit capture, though it introduces short-term margin volatility.

2. Platform Expansion via Expedite Differentiation

Expedite, the AI-powered autonomous bag screening solution, is gaining traction—now present in 6% of the customer base. Its integration with Express creates a unified workflow, lowering alert rates (less than 2% in a major school deployment) and stacking ARPU while improving customer acquisition efficiency.

3. Vertical Penetration and Policy Tailwinds

Education remains the anchor vertical, with new wins across K-12 and municipalities in multiple states. Healthcare, sports, and enterprise segments are scaling, with Evolve now serving over 30 Fortune 500 companies. Policy momentum, such as Georgia’s House Bill 1023, could reinforce long-term adoption, though guidance does not assume legislative upside.

4. Operating Leverage and Talent Investment

Management is investing in core systems, AI talent, and process controls to support scale. Leadership signals confidence in achieving EBITDA margins above the previously stated 10-15% long-term target, citing growing installed base, ARPU expansion, and improved customer acquisition economics.

5. Supply Chain and Manufacturing Resilience

The Plexus partnership is on track to expand production capacity and global reach, with onboarding progressing as planned. Semiconductor supply constraints have been proactively managed, with premium component pricing already factored into guidance.

Key Considerations

This quarter marks a structural inflection as Evolve’s purchase deal mix and platform expansion alter the revenue and margin cadence, while recurring revenue scale and operational investments lay the groundwork for durable, high-visibility growth.

Key Considerations:

  • Deal Mix Volatility: Purchase-heavy quarters drive revenue upside but introduce margin compression and revenue recognition lumpiness.
  • Recurring Revenue Visibility: Growing ARR and RPO enhance predictability, but the transition to a more normalized recurring mix will not be complete until after 2026.
  • Expedite as Growth Multiplier: Expedite’s rapid adoption both increases ARPU and shortens sales cycles, with integration advantages difficult for legacy competitors to match.
  • Margin Expansion Path: Management’s upgraded long-term EBITDA leverage view is contingent on continued scale, pricing discipline, and efficient cost structure.
  • Policy and Market Catalysts: Legislative initiatives and acute security events can accelerate adoption, but are not embedded in baseline forecasts.

Risks

Revenue and margin are sensitive to deal mix and timing, with purchase-heavy quarters driving short-term volatility. The transition to a normalized recurring revenue model may cloud near-term comparability. Competitive threats exist from legacy X-ray players, though Evolve’s AI integration and unified platform offer differentiation. Macro events, supply chain disruptions, and policy uncertainty remain material factors to monitor.

Forward Outlook

For Q2, Evolve expects:

  • Sequential revenue decline due to prior year backlog fulfillment, not underlying demand weakness.
  • Gross margin improvement as purchase mix moderates.

For full-year 2026, management raised guidance:

  • Revenue of $175 to $180 million (20-23% YoY growth).
  • Year-end ARR of $145 to $150 million (20-25% YoY growth).
  • Full-year adjusted EBITDA margin in the high single digits, up from 7.6% in 2025.

Management cited:

  • Higher purchase mix, strong pricing, and ARPU trends as drivers of the guidance raise.
  • H2 2026 as the final period of major fulfillment model impact, with revenue normalization expected post-2026.

Takeaways

Evolve’s Q1 is a case study in how deal mix and platform expansion can drive both top-line acceleration and near-term margin complexity, with the underlying business model delivering increasing predictability and long-term leverage.

  • Purchase Mix Inflection: The 64% purchase deal mix catalyzed record revenue but compressed gross margin, a dynamic expected to normalize as recurring revenue grows.
  • Expedite Momentum: Expedite’s rapid adoption is stacking ARPU and shortening sales cycles, reinforcing Evolve’s competitive moat in integrated security screening.
  • Leverage Trajectory: Investors should watch for continued ARR and RPO growth, margin normalization, and updates on long-term EBITDA margin targets at Investor Day.

Conclusion

Evolve Technology’s Q1 2026 results showcase a business at an inflection point, balancing the near-term impact of deal mix shifts with the structural advantages of a growing subscription base and differentiated platform. Management’s upgraded guidance and margin leverage outlook underscore confidence in the path to durable, high-visibility growth.

Industry Read-Through

Evolve’s results highlight a broader industry trend: security technology buyers are demanding integrated, AI-powered solutions that deliver both operational efficiency and safety assurance at scale. The rapid adoption of autonomous screening in education, healthcare, and enterprise verticals signals accelerating replacement of legacy X-ray and manual screening. Competitors lacking integrated hardware-software platforms and AI-enabled workflows face increasing competitive pressure. Legislative momentum for proactive security creates additional sector tailwinds, though policy-driven demand remains an upside lever rather than a baseline assumption. The normalization of recurring revenue models in hardware-centric industries is likely to become a defining theme for security technology providers in the coming years.

EVLV Technology Security Subscription AI Hardware Recurring Revenue Platform